Clinical Trial of Recombinant Hepatitis E Vaccine

Hepatitis E

AbbVie – Hepatitis C Virus Infection

Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease Morbidity and Mortality of Hepatitis E Virus Infections in Belgium Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E Role of Cytokines in Hepatitis E Virus Infection During Pregnancy Seroprevalence Hepatitis E Infection in Healthy Blood Donors Safety Study of Hepatitis E Vaccine (HEV239) Seroprevalence of Hepatitis E in People With an Organ Transplant HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE) Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection. A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine) HEV in Patients With Acute Non-A, Non-B, Non-C Hepatitis in Al-Rajhy University Hospital for Liver The Epidemiology of Hepatitis E Virus Infection in Israel and Potential Risk Factors A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli) Clinical Trial of Recombinant Hepatitis E Vaccine A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial) Seroprevalence of Hepatitis E in HIV Positive Patients in Basque Country in 2016 (VIhVhEpb) Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®） A Clinical Trial to Evaluate a Recombinant Hepatitis E Vaccine in Healthy Adults A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)